Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Metabomed

Website

Advertisement

Advertisement

1 Broadway Ste 14
Cambridge, MA 02142
https://www.metabomed.com

Metabomed is a biotechnology company based in Cambridge, MA, specializing in drug discovery and development.

With a focus on innovative approaches and cutting-edge technologies, Metabomed aims to address unmet medical needs and advance novel therapies for various diseases.

Generated from their business information

Also at this address

CEO Express Co Inc

Potomac Group

Moore James

China Pharma Hub Corp

Own this business?
Claim it
See a problem?

You might also like

Nanobiotix Corp

Nanobiotix Corp is a biotechnology company based in Cambridge, MA that specializes in the development of innovative cancer therapies. They have recently achieved a significant $20 million development milestone payment for their ongoing global Phase 3 Head and Neck Cancer Study, and have also raised $55 million through a capital increase. With a strong focus on research and development, Nanobiotix is dedicated to advancing their science pipeline and collaborating with partners to bring effective treatments to patients. Through their cutting-edge technology, Nanobiotix aims to revolutionize cancer treatment by leveraging nanomedicine to enhance the efficacy of radiation therapy. Their preliminary results from Phase 1 trials in pancreatic cancer and head and neck cancer have shown promising outcomes, further highlighting their commitment to improving patient outcomes. With a dedicated team of leaders, a scientific advisory board, and a strong presence in the media and investor community, Nanobiotix is poised to make a significant impact in the field of oncology.Generated from the website

TCR 2 Inc

Adaptimmune is a Cambridge-based company dedicated to revolutionizing the treatment of solid tumor cancers. Utilizing a proprietary cell therapy platform, they engineer a patient's own cells to combat their cancer, offering a personalized approach that has the potential to significantly improve the patient experience. With their first Biologics License Application (BLA) submitted to the FDA, Adaptimmune is on the cusp of a new era in cancer treatment. Their goal is to commercialize the first engineered T-cell therapy for solid tumors, aiming to reshape the landscape of cancer care with a single infusion.Generated from the website
Blood derivatives

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company based in Cambridge, MA, focused on developing novel therapies for patients with neurological diseases. The company's research and development efforts are centered around targeting a specific biological pathway to address unmet medical needs in neurodegenerative disorders. Through innovative approaches and cutting-edge science, Disarm Therapeutics aims to advance potential treatments that have the potential to make a meaningful impact on the lives of individuals affected by neurological conditions. The company's commitment to scientific excellence and patient-centric focus drives its mission to create transformative therapies for those in need. Generated from their business information
United States›Massachusetts›Cambridge›Metabomed

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell